ACA VANCOMYCIN (VANC) METHOD

Radioimmunoassay, Vancomycin

E.I. DUPONT DE NEMOURS & CO., INC.

The following data is part of a premarket notification filed by E.i. Dupont De Nemours & Co., Inc. with the FDA for Aca Vancomycin (vanc) Method.

Pre-market Notification Details

Device IDK892900
510k NumberK892900
Device Name:ACA VANCOMYCIN (VANC) METHOD
ClassificationRadioimmunoassay, Vancomycin
Applicant E.I. DUPONT DE NEMOURS & CO., INC. DU PONT-BMP22/1152 Wilmington,  DE  19880
ContactChristopher Bentsen
CorrespondentChristopher Bentsen
E.I. DUPONT DE NEMOURS & CO., INC. DU PONT-BMP22/1152 Wilmington,  DE  19880
Product CodeLEH  
CFR Regulation Number862.3950 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1989-04-20
Decision Date1989-05-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.